Join

Compare · APEN vs SNN

APEN vs SNN

Side-by-side comparison of Apollo Endosurgery Inc. (APEN) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both APEN and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
  • SNN is the larger of the two at $13.01B, about 64.7x APEN ($201.0M).
  • SNN has hit the wire 11 times in the past 4 weeks while APEN has been quiet.
  • SNN has more recent analyst coverage (23 ratings vs 6 for APEN).
MetricAPENSNN
Company
Apollo Endosurgery Inc.
Smith & Nephew SNATS Inc.
Price
$9.99+0.71%
$30.48-0.42%
Market cap
$201.0M
$13.01B
1M return
-
+1.40%
1Y return
-
+2.04%
Industry
Industrial Specialties
Industrial Specialties
Exchange
NASDAQ
NYSE
IPO
News (4w)
0
11
Recent ratings
6
23
APEN

Apollo Endosurgery Inc.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

SNN

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.